Evidence map›Paper›PMID 32524537›Full record

SynthesisActa neurologica Belgica2020

A complication of coronavirus disease 2019: delirium.

Gabriele Cipriani, Sabrina Danti, Angelo Nuti, Cecilia Carlesi, Claudio Lucetti, Mario Di Fiorino

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Acta neurologica Belgica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gabriele CiprianiNeurology Unit, Versilia Hospital, via Aurelia, Lido di Camaiore, 55043, Lucca, Lu, Italy. cprgrl@gmail.com.ORCID http://orcid.org/0000-0001-6334-890X
Sabrina DantiClinical and Health Psychology Unit, Hospital of Pontedera, Pontedera, Italy.
Angelo NutiNeurology Unit, Versilia Hospital, via Aurelia, Lido di Camaiore, 55043, Lucca, Lu, Italy.
Cecilia CarlesiNeurology Unit, Versilia Hospital, via Aurelia, Lido di Camaiore, 55043, Lucca, Lu, Italy.
Claudio LucettiNeurology Unit, Versilia Hospital, via Aurelia, Lido di Camaiore, 55043, Lucca, Lu, Italy.
Mario Di FiorinoPsychiatry Unit, Versilia Hospital, Lido di Camaiore, Italy.
Ospedale Versilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is predominantly a respiratory disease. However, some cases exhibit other features including Central Nervous System symptoms. In the older adult, COVID-19 may present with atypical symptoms, including delirium and its complications. The objective of this study is to describe the relationship between the new type of coronavirus infection and delirium. Systematic research (Cochrane Library and PubMed) was carried out (only upper time limit: April 2020). Publications found through this indexed search were reviewed and manually screened to identify relevant studies. Search terms used included "COVID-19, Delirium, Dementia, Intensive Care Unit". We manually added articles identified through other sources (i.e., key journals). Older people are at the greatest risk from COVID-19. If infected, they may present delirium. Moreover, it is not exclusive to older people. Delirium is not inevitable; rather, it is preventable. Delirium prevention programs are even more crucial in the era of COVID-19 and cannot be allowed to wither despite the challenges of integrating delirium prevention with COVID-19 care. An acute change in condition, behaviour, or mental status should prompt a delirium screen. As regards the treatment, it is advisable to use non-pharmacological interventions first where possible. Medication may be needed for patients with agitation where there is intractable distress or high risk to self/others.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19DeliriumHumansPandemicsPneumonia, ViralSARS-CoV-2COVID-19DeliriumDementiaIntensive-care unit

Identifiers

PMID32524537
PMCPMC7286634
OpenAlexW3033433167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.